Survival data in HGBL subgroups. Survival was evaluated from eligibility (A, OS) or from infusion (B, PFS; C, OS). Patients with HGBL-TH or -DH MYC-BCL2 have a significantly lower OS from eligibility (P = .037). NA, non atteint (not reached).